Loading...
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
BACKGROUND: Systemic mastocytosis (SM) comprises a heterogeneous group of disorders characterized by the proliferation of clonal mast cells in skin and various internal organs. Omalizumab is an established, labelled therapy for allergic asthma and chronic urticaria, but its experience in the efficac...
Na minha lista:
| Udgivet i: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6766258/ https://ncbi.nlm.nih.gov/pubmed/31637065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/3787586 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|